Your browser doesn't support javascript.
loading
Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial.
de Boer, Stephanie M; Powell, Melanie E; Mileshkin, Linda; Katsaros, Dionyssios; Bessette, Paul; Haie-Meder, Christine; Ottevanger, Petronella B; Ledermann, Jonathan A; Khaw, Pearly; Colombo, Alessandro; Fyles, Anthony; Baron, Marie-Helene; Kitchener, Henry C; Nijman, Hans W; Kruitwagen, Roy F; Nout, Remi A; Verhoeven-Adema, Karen W; Smit, Vincent T; Putter, Hein; Creutzberg, Carien L.
Afiliação
  • de Boer SM; Department of Radiation Oncology, Leiden University Medical Center, Leiden, Netherlands. Electronic address: s.m.de_boer.onco@lumc.nl.
  • Powell ME; Department of Clinical Oncology, Barts Health NHS Trust, London, UK.
  • Mileshkin L; Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia.
  • Katsaros D; Department of Surgical Sciences, Gynecologic Oncology, Città della Salute and S Anna Hospital, University of Torino, Torino, Italy.
  • Bessette P; NCIC-CTG, Department of Obstetrics and Gynaecology, University of Sherbrooke, QC, Canada.
  • Haie-Meder C; Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France.
  • Ottevanger PB; Department of Medical Oncology, Radboudumc, Nijmegen, Netherlands.
  • Ledermann JA; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK.
  • Khaw P; Division of Radiation Oncology & Cancer Imaging, Peter MacCallum Cancer Center, East Melbourne, VIC, Australia.
  • Colombo A; Department of Radiation Oncology, Azienda Ospedaliera della Provincia di Lecco, Italy.
  • Fyles A; NCIC-CTG, Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Baron MH; Department of Radiotherapy, Centre Hospitalier Régional Universitaire de Besançon, Besançon, France.
  • Kitchener HC; Institute of Cancer Sciences, University of Manchester, Manchester, UK.
  • Nijman HW; Department of Gynaecologic Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
  • Kruitwagen RF; Department of Gynaecology and Obstetrics, and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands.
  • Nout RA; Department of Radiation Oncology, Leiden University Medical Center, Leiden, Netherlands.
  • Verhoeven-Adema KW; Comprehensive Cancer Center The Netherlands, Leiden, Netherlands.
  • Smit VT; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands.
  • Putter H; Department of Medical Statistics, Leiden University Medical Center, Leiden, Netherlands.
  • Creutzberg CL; Department of Radiation Oncology, Leiden University Medical Center, Leiden, Netherlands.
Lancet Oncol ; 17(8): 1114-1126, 2016 Aug.
Article em En | MEDLINE | ID: mdl-27397040
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Endométrio / Cistadenocarcinoma Seroso / Adenocarcinoma de Células Claras / Radioterapia Adjuvante / Quimiorradioterapia Adjuvante Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Endométrio / Cistadenocarcinoma Seroso / Adenocarcinoma de Células Claras / Radioterapia Adjuvante / Quimiorradioterapia Adjuvante Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article